News

01.08.21

GEN Article: Supercharge Antibody Discovery Workflows with High-Throughput SPR

Read More

News

12.14.20

PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization

Read More

News

12.01.20

Carterra® Announces the Appointment of Joseph D. Keegan, PhD as Executive Chairman of the Board of Directors

Read More

News

08.17.20

Immunity Monitoring of COVID-19 Patients Using a SARS-CoV-2 Label-free Assay

Read More

News

07.06.20

GEN Article: Eliminating Bottlenecks in mAb Drug Discovery

Twist Biopharma screens massive antibody libraries with the Carterra LSA to discover therapeutic antibodies in just weeks.

Read More

News

06.29.20

Podcast: Tim Germann our Chief Commercial Officer Discusses how Carterra has Become an Innovator and Driving Force in Therapeutic Antibody Discovery

Listen to Podcast

News

06.18.20

Nature Article: Speeding Antibody Screening for Drug Development

Advanced screening technology can dramatically accelerate the hunt for effective treatments for cancer, COVID-19 and more.

Read More

News

04.09.20

Video: Carterra has been Selected by the Gates Foundation to Help Solve the COVID-19 Pandemic

Watch Video

News

03.31.20

Carterra® Inc. Selected by the La Jolla Institute of Immunology to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)

Read More

News

03.12.20

Biocompare Article on How Epitope Binning Streamlines Discovery and Exploits Diversity

Epitope binning screens and characterizes antibodies in one step. Studying kinetics, affinity, and epitope relationships in high throughput allows characterization of antibody libraries generated against a specific antigen through B cell cloning, phage display, or hybridoma technologies.

Read More